THall
9 hours ago
The only reason a CEO would allow their company to be placed on the Expert Market is if they wanted the price to tank. Most shareholders only have the option to sell. It doesn't take a rocket scientist to see this company is going private and shareholders are getting screwed. By moving to the EM management and insiders are assured no new shareholders can purchase shares. They know as time passes bag holders will eventually sell at .0001 for a tax loss. The only ones that can buy are out of the US so that gives the company and its insiders the opportunity to repurchase ALL the outstanding shares at deep discount without having to make an offer to shareholder to buy them out.
Shareholders would not accept a buyout offer of .0001 per share but by the company going to the EM they have no other options. The company can buy back all the shares for less than $100k now. If they made an offer to shareholders to buy them out that price would be much higher
Authorized Shares
2,000,000,000
07/22/2024
Outstanding Shares
936,463,730
StocktonCA
11 hours ago
The OTC Markets has identified specific circumstances in which a Caveat Emptor designation is assigned. Once assigned, more often than not, it is not removed. The circumstances are set forth below.
Promotion/Spam Without Adequate Current Information
The security is being promoted to the public, but adequate current information about the company has not been made available to the public.
Investigation of Fraud or Other Criminal Activities
OTC Markets Group becomes aware of an investigation of fraudulent or other criminal activity involving the company, its securities, or insiders.
Suspension/Halt
A regulatory authority or an exchange has halted or suspended trading for public interest concerns (i.e., not a news or earnings halt).
Undisclosed Corporate Actions
The security or company is the subject of a corporate action, such as a reverse merger, stock split, or name change, without adequate current information being publicly available.
Unsolicited Quotes
The security has only been quoted on an unsolicited basis since it entered the public markets, and the company has not made adequate current information available to the public.
Other Public Interest Concern
OTC Markets Group has determined that there is a public interest concern regarding security. Such concerns may include but are not limited to promotion, spam, or disruptive corporate actions even when adequate current information is available.
meixatech
1 day ago
The two 2024 publications that I posted both had Lippa and Cerne as authors. I have more than 80 publications in high tier journals (i.e., I know a lot about science/publishing). Many of these medical journals have three reviewers, all of whom are highly respected in their fields. Cerne works for Eli Lilly. He participated in the research and writing of those papers in order to be an author. So, Eli Lilly paid, at least to some extent, the research and perhaps the publication fee. Possible scenario: Lippa left Eli Lilly to develop the few prospects in the RSPI pipeline using funds from stock sales and grants, thus saving development funds. Under this possible scenario, when will Lilly buy out RSPI?